University Hospital Southampton NHS Foundation Trust (UHS) (Site UK014), Tremona Road
Welcome,         Profile    Billing    Logout  
 3 Trials 
6 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Team, Research
NCT05172193: Safety & Immunogenicity of Booster SARS-CoV-2 Vaccine (Vero Cell)

Recruiting
2
600
RoW
SARS-COV-2 Vaccine (Vero Cell-Sinopharm) Inactivated
PT. Kimia Farma (Persero) Tbk
COVID-19
09/23
09/23
NCT04464980: Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD)

Recruiting
2
2190
US
SL-BUP, sublingual buprenorphine, Suboxone, XR-BUP, extended-release buprenorphine, CAM2038, Brixadi, XR-NTX, extended-release naltrexone, Vivitrol, MM, MMR, MMD
NYU Langone Health, New York State Psychiatric Institute, Columbia University, Harvard Medical School (HMS and HSDM), Mclean Hospital, National Institute on Drug Abuse (NIDA), The Emmes Company, LLC
Opioid Use Disorder (OUD)
07/26
12/26
ETX-DS-005, NCT06283212: A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome

Recruiting
1/2
4
Europe
ETX101
Encoded Therapeutics
Dravet Syndrome
12/29
12/29
NCT06303648: A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy Subjects

Recruiting
1
24
RoW
Methylone
Transcend Therapeutics
Post Traumatic Stress Disorder
05/24
05/24
CDR404-001, NCT06402201: First in Human Study of CDR404 in HLA-A*02:01 Participants with MAGE-A4 Expressing Solid Tumors

Recruiting
1
42
Europe, US
CDR404
CDR-Life AG
Select Advanced Solid Tumors
06/26
12/27
NCT06654999: How Consistent is the Output of DERM, When Used to Assess Images of Potentially Cancerous Skin Lesions.

Not yet recruiting
N/A
115
Europe
Deep Ensemble for the Recognition of Malignancy (DERM)
Skin Analytics Limited
Skin Cancer, Melanoma of Skin, Squamous Cell Cancer, Basal Cell Cancer
02/25
03/25

Download Options